Vedanta Biosciences Patents – Key Insights and Stats

Vedanta Biosciences has a total of 80 patents globally, out of which 12 have been granted. Of these 80 patents, more than 76% patents are active. The United States of America is where Vedanta Biosciences has filed the maximum number of patents, followed by Europe and Japan. Parallelly, the United States of America seems to be the main focused R&D centre of Vedanta Biosciences.

Vedanta Biosciences was founded in the year 2010 by Alexander Rudensky, Bernat Olle, Dan Littman, David Steinberg and Ruslan Medzhitov. The company is a developer of immunotherapies designed to treat immune-mediated and infectious diseases.

Do read about some of the most popular patents of Vedanta Biosciences which have been covered by us in this article and also you can find Vedanta Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vedanta Biosciences patent portfolio.

How many patents does Vedanta Biosciences have?

Vedanta Biosciences has a total of 80 patents globally. These patents belong to 16 unique patent families. Out of 80 patents, 61 patents are active.

How Many Patents did Vedanta Biosciences File Every Year?

Vedanta Biosciences Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVedanta Biosciences Applications FiledVedanta Biosciences Patents Granted
202263
202171
2020151
2019153
2018153
2017191
20142 –

How many Vedanta Biosciences patents are Alive/Dead?

Vedanta Biosciences Patents Portfolio

How Many Patents did Vedanta Biosciences File in Different Countries?

Vedanta Biosciences Worldwide Patents

Countries in which Vedanta Biosciences Filed Patents

CountriesPatents
United States Of America21
Europe10
Japan9
Hong Kong (S.A.R.)6
China5
Australia5
Canada4
Korea (South)2
India2
Israel1
Mexico1

Where are the Research Centres of Vedanta Biosciences Patents Located?

The research centre of the Vedanta Biosciences Patents is the United States Of America.

10 Best Vedanta Biosciences Patents

US20120149584A1 is the most popular patent in the Vedanta Biosciences portfolio. It has received 160 citations so far from companies like uBiome, Accelerate Diagnostics and Seres Health.

Below is the list of 10 most cited patents of Vedanta Biosciences:

Publication NumberCitation Count
US20120149584A1160
US9764019B216
KR1020190030687A15
WO2017218680A113
US10130695B212
US9999641B212
US10064904B29
WO2018081550A17
US20190134179A16
WO2020037271A15

What Percentage of Vedanta Biosciences US Patent Applications were Granted?

Vedanta Biosciences (Excluding its subsidiaries) has filed 16 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 9 have been granted leading to a grant rate of 81.8%.

Below are the key stats of Vedanta Biosciences patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Vedanta Biosciences?

Law FirmTotal ApplicationsSuccess Rate
Vedanta Biosciences Inc11100.00%
Wolf Greenfield & Sacks Pc533.33%

What are Vedanta Biosciences key innovation segments?

What Technologies are Covered by Vedanta Biosciences?

The chart below distributes patents filed by Vedanta Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Vedanta Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Vedanta Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by the Vedanta Biosciences?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.